Page 5 - Guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma

Kapoor et al.

9. Huang WW, Huang HY, Liao AC et al. Primary urothelial carcinoma of the upper tract: important clinico-
should be performed at months 3, 6, 12, 18, 24 and annu- pathological factors predicting bladder recurrence after surgical resection. Pathol Int 2009;59:642-9.
ally thereafter (Grade C). Cystoscopy and ureteroscopy may http://dx.doi.org/10.1111/j.1440-1827.2009.02420.x
be omitted from the surveillance protocol after 10 years of 10. Kamihira O, Hattori R, Yamaguchi A, et al. Laparoscopic radical nephroureterectomy: a multicenter analysis
recurrence-free survival (Grade D). in Japan. Eur Urol 2009;55:1397-409. http://dx.doi.org/10.1016/j.eururo.2009.03.003
11. Kikuchi E, Horiguchi Y, Nakashima J, et al. Lymphovascular invasion independently predicts increased
Surveillance for any grade pT>2 or pN+ patients disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol
2005;174:2120-4. http://dx.doi.org/10.1097/01.ju.0000181801.22474.8b
12. Kim DS, Lee YH, Cho KS, et al. Lymphovascular invasion and pT stage are prognostic factors in patients
History, physical examination, blood work, urine cytology, treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology
and cystoscopy should be performed at months 3, 6, 12, 18, 2009;75:328-32. http://dx.doi.org/10.1016/j.urology.2009.07.1350
24 and annually thereafter (Grade C). CXR and CTU should 13. Koda S, Mita K, Shigeta M, et al. Risk factors for intravesical recurrence following urothelial carcinoma
be performed at months 3, 6, 12, 18, 24, 30, 36 and annually of the upper urinary tract: no relationship to the mode of surgery. Jpn J Clin Oncol 2007;37:296-301.
http://dx.doi.org/10.1093/jjco/hym016
thereafter (Grade C). Following nephron-sparing procedures, 14. Lee SE, Hong SK, Han BK, et al. Prognostic significance of tumor necrosis in primary transitional cell
ipsilateral ureteroscopy with selective cytology or biopsy carcinoma of the upper urinary tract. Jpn J Clin Oncol 2007;37:49-55. http://dx.doi.org/10.1093/
should be performed at months 3, 6, 12, 18, 24 and annu- jjco/hyl123
ally thereafter (Grade C). Cystoscopy and ureteroscopy may 15. Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract
be omitted from the surveillance protocol after 10 years of cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008;54:1127-37. http://
dx.doi.org/10.1016/j.eururo.2008.01.054
recurrence-free survival (Grade D). 16. Li WM, Shen JT, Li CC, et al. Oncologic outcomes following three different approaches to the distal ureter
and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol
Competing interests: Dr. Kapoor is a member of the Speakers bureau for, and has received grants 2010;57:963-9. http://dx.doi.org/10.1016/j.eururo.2009.12.032
and honoraria from, Pfizer Oncology, GSK Oncology, Novartis Oncology and Amgen. He has also 17. Lin, WC, Hu FC, Chung SD, et al. The role of lymphovascular invasion in predicting the prognosis of
participated in clinical trials within the past 2 years with NCIC, Pfizer, GSK, Novartis and Amgen. clinically localized upper tract urothelial carcinoma (pT1-3cN0M0). J Urol 2008;180:879-85. http://
Dr. Allard does not have an affiliation with a pharmaceutical, medical device or communications dx.doi.org/10.1016/j.juro.2008.05.022
organization. Dr. Black is a member of the ad hoc Advisory Boards for Amgen, Janssen, Ferring 18. Manabe D, Saika T, Ebara S, et al. Comparative study of oncologic outcomes of laparoscopic nephrour-
and Astellas. He has received an industry-partnered grant (2012) from GenoneDx. Dr. Kassouf eterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology
2007;69:457-61. http://dx.doi.org/10.1016/j.urology.2006.11.005
is an Advisory Board member and a speaker for Amgen and Astellas. He has also received grants 19. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: A series from the Upper
and honoraria from these companies. He is currently participating in unpaid clinical trials within the Tract Urothelial Carcinoma Collaboration. Cancer 2009;115:1224-33. http://dx.doi.org/10.1002/
past 2 years. Dr. Morash does not have an affiliation with a pharmaceutical, medical device or cncr.24135
communications organization. Dr. Rendon is a member of the Advisory Board and the Speakers 20. Muntener M, Schaeffer EM, Romero FR, et al. Incidence of local recurrence and port site metastasis
bureau for Amgen, Astellas, Ferring and Janssen. after laparoscopic radical nephroureterectomy. Urology 2007;70:864-8. http://dx.doi.org/10.1016/j.
urology.2007.07.027
21. Roscigno M, Cozzarini C, Bertini R, et al. Prognostic value of lymph node dissection in patients with
muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008;53:794-802. http://
This paper has been peer-reviewed. dx.doi.org/10.1016/j.eururo.2008.01.008
22. Saito K, Kawakami S, Fujii Y, et al. Lymphovascular invasion is independently associated with poor
prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol
References 2007;178:2291-6. http://dx.doi.org/10.1016/j.juro.2007.08.019
23. Schatteman P, Chatzopoulos C, Assenmacher C, et al. Laparoscopic nephroureterectomy for upper
1. Munoz JJ, Ellison LM, Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey. Eur Urol
J Urol 2000;164:1523-5. http://dx.doi.org/10.1016/S0022-5347(05)67019-X 2007;51:1633-8. http://dx.doi.org/10.1016/j.eururo.2006.09.016
2. Roupret M, Babjuk E, Comperat R, et al. European guidelines on upper tract urothelial carcinomas: 2013 24. Shimomura T, Ohtsuka N, Yamada H, et al. Patterns of failure and influence of potential prognostic factors
update. Eur Urol 2013;63:1059-71. http://dx.doi.org/10.1016/j.eururo.2013.03.032 after surgery in transitional cell carcinoma of the upper urinary tract. Int J Clin Oncol 2009;14:213-8.
3. Argyropoulos AN, Tolley DA. Upper urinary tract transitional cell carcinoma: current treatment overview http://dx.doi.org/10.1007/s10147-008-0837-4
of minimally invasive approaches. BJU Int 2007;99:982-7. http://dx.doi.org/10.1111/j.1464- 25. Simone G, Papalia R, Guaglianone S, et al. Laparoscopic versus open nephroureterectomy: perioperative
410X.2007.06870.x and oncologic outcomes from a randomised prospective study. Eur Urol 2009;56:520-6. http://dx.doi.
4. Allard, C, Alamri, A, Dason, S et al. The method of bladder cuff excision during laparoscopic radical org/10.1016/j.eururo.2009.06.013
nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma. World J Urol 26. Simone G, Papalia R, Loreto A, et al. Independent prognostic value of tumour diameter and tumour necrosis
2012;31:175-81. http://dx.doi.org/10.1007/s00345-012-0915-0 in upper urinary tract urothelial carcinoma. BJU Int 2009;103:1052-7. http://dx.doi.org/10.1111/
5. Berger A, Haber GP, Kamoi K, et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell j.1464-410X.2008.08134.x
carcinoma: oncological outcomes at 7 years. J Urol 2008;180:849-54. http://dx.doi.org/10.1016/j. 27. Wu CF, Pang ST, Chen CS, et al. The impact factors on prognosis of patients with pT3 upper urinary tract
juro.2008.05.042 transitional cell carcinoma. J Urol 2007;178:446-50. http://dx.doi.org/10.1016/j.juro.2007.03.115
6. Bolenz C, Fernandez MI, Trojan L, et al. Lymphovascular invasion and pathologic tumor stage are significant 28. Xylinas E, Rink M, Cha EK, et al. Impact of distal ureter management on oncologic outcomes following
outcome predictors for patients with upper tract urothelial carcinoma. Urology 2008:72:364-9. http:// radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 2012 May 4 Epub. http://
dx.doi.org/10.1016/j.urology.2008.04.032 dx.doi.org/10.1016/j.eururo.2012.04.052
7. El Fettouh HA, Rassweiler JJ, Schulze M, et al. Laparoscopic radical nephroureterectomy: results of 29. Ouzzane A, Colin P, Xylinas E et al. Ureteral and multifocal tumours have worse prognosis than renal
an international multicenter study. Eur Urol 2002;42:447-52. http://dx.doi.org/10.1016/S0302- pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol
2838(02)00370-6 2011;60:1258-65. http://dx.doi.org/10.1016/j.eururo.2011.05.049
8. Hsueh TY, Huang YH, Chiu AW, et al. Survival analysis in patients with upper urinary tract transitional 30. Ng CK, Shariat SF, Lucas SM, et al. Does the presence of hydronephrosis on preoperative axial CT imaging
cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy. BJU Int predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?
2007;99:632-6. http://dx.doi.org/10.1111/j.1464-410X.2006.06665.x Urol Oncol 2011;29:27-32. http://dx.doi.org/10.1016/j.urolonc.2008.10.023

310 CUAJ • September-October 2013 • Volume 7, Issues 9-10